NIRAMAI_HEALTH_ANALYTIX_U

NIRAMAI HEALTH ANALYTIX UK LTD

Financial Statements

Year ended 31 March 2026

Contents

Officers and Professional Advisors

1

Directors Report

2

Statement of Income and Retained Earnings

3

Statement of Financial Position

4

Notes to the financial statements

5

NIRAMAI HEALTH ANALYTIX UK LTD

Officers and Professional Advisors

Directors

Dr Geetha Manjunath

K Siva Teja

Registered Office

6th Floor

9 Appold Street

London

United Kingdom

EC2A 2AP

NIRAMAI HEALTH ANALYTIX UK LTD

Directors' Report

Year ended 31 March 2026

The directors present this report and the unaudited financial statements of the company for the period ended 31 March 2026.

Principal Activities

The company was incorporated on 28 January 2022 and its principal activities was that of providing a breast cancer detection solution.

Directors

The directors' who served the company during the period are as follows:

1.

Dr Geetha Manjunath (appointed 28 January 2022)

2.

K Siva Teja (appointed 28 January 2022)

Small Company Provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies' exemption.

This report was approved by the board of directors on 23 April 2026 and signed on behalf of the board by:

Dr Geetha Manjunath

Director

Page 4

NIRAMAI HEALTH ANALYTIX UK LTD

Statement of Income and Retained Earnings

Period ended 31 March 2026

March 2026

March 2025

Note

£

-

Administrative expenses

-

Profit/(Loss) Before Taxation

-

Taxation

-

Loss for the Financial Year and Total Comprehensive profit

-

Page 5

NIRAMAI HEALTH ANALYTIX UK LTD

Statement of Financial Position

31 March 2026

Company registration number: 13877488

31 March 2026

31 March 2025

Note

£

CURRENT LIABILITIES

Creditors

6

1,230

CAPITAL AND RESERVES

Share capital

7

100

Profit and loss reserves

(1,330)

1,230

The financial statements have been prepared and delivered in accordance with the provisions applicable to the companies subject to the small companies' regime.

For the period ending 31 March 2026, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

*

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

*

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements were approved by the board of directors and authorized for issue on 23 April 2026, and are signed on behalf of the board by:

Dr Geetha Manjunath

Director

Page 6

NIRAMAI HEALTH ANALYTIX UK LTD

Notes to the Financial Statements

31 March 2026

1.

General Information

The Company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6th Floor, 9 Appold Street, London, United Kingdom, EC2A 2AP.

2.

Accounting policies

Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Financial instruments

3.

Judgements and Key Sources of Estimation Uncertainty:

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The directors are of the opinion that there are no estimates or assumptions that have a significant risk of causing a material adjustment to the carrying value of assets and liabilities within the next financial year.

Page 7

NIRAMAI HEALTH ANALYTIX UK LTD

Notes to the Financial Statements (Continued)

31 March 2026

4.

Employee Numbers:

There are no employees in the company during the period of operations.

5.

Creditors: amounts falling due within one year

31 March 2026

31 March 2025

£

Amounts due to creditors

1,230

6.

Share capital

31 March 2026

31 March 2025

£

100 Ordinary shares of £1 each (unpaid)

100

Niramai Health Analytix UK Ltd does not hold an active bank account to accept share capital funds from the shareholder M/s. Niramai Health Analytix Pvt Ltd, India.

7.

Parent company

The Company is a subsidiary of NIRAMAI Health Analytix Private Limited, a company registered in India. The registered office address is Flat A7-506, Elita Promenade, J P Nagar 7th Phase, Bangalore, Karnataka, 560078, India.

─-

Page 8